Wells Fargo’s Bio-Techne TECH Stock Holding History

Wells Fargo’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,000	Closed	-$1.25M	–	7592
2026 Q1	$1.25M	Buy	+24,000	New	+$1.44M	﹤0.01%	3604

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wells Fargo's TECH Position: Q2 2026 in Review

Wells Fargo reduced its Bio-Techne (TECH) stake by 30% in Q2 2026, selling an estimated $3.98M and leaving 169,378 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

Wells Fargo first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $126M in Q3 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Wells Fargo held 169,378 shares of Bio-Techne worth $12M as of Q2 2026.
Wells Fargo sold 73,684 Bio-Techne shares in Q2 2026, an estimated $3.98M.
Bio-Techne made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2048 holding.
Wells Fargo first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Bio-Techne position peaked at $126M in Q3 2021.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.